Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 36

    Horizon thyroid eye disease drug Tepezza priced at USD 14900 per vial

    Horizon thyroid eye disease drug Tepezza priced at USD 14900 per vial

    Medical Dialogues Bureau22 Jan 2020 10:06 AM IST
    Horizon said the drug, Tepezza will earn about $105 million in milestone payments in the first half of 2020. The company last week raised its...
    Zydus, China Medical System enter licensing agreement for desidustat

    Zydus, China Medical System enter licensing agreement for desidustat

    Medical Dialogues Bureau21 Jan 2020 3:15 PM IST
    Under the license agreement, CMS will pay Zydus an initial upfront payment, regulatory milestones, sales milestones and royalties on net sales of the...
    Alembic Pharma gets two USFDA observations for Karkhadi facility

    Alembic Pharma gets two USFDA observations for Karkhadi facility

    Medical Dialogues Bureau21 Jan 2020 12:50 PM IST
    New Delhi: Drugs maker, Alembic Pharma recently announced that the company's API facility located at Karkhadi has received Form 483 with two...
    Mumbai: Fake pharmacy call centre selling prescription drugs for impotence busted; 2 held

    Mumbai: Fake pharmacy call centre selling prescription drugs for impotence busted; 2 held

    Farhat Nasim21 Jan 2020 11:40 AM IST
    Mumbai: In a major crackdown, Mumbai Crime Branch has busted a racket targeting American Nationals and duping them under the pretext of providing...
    Strides Pharma arm gets EIR from USFDA for Florida facility

    Strides Pharma arm gets EIR from USFDA for Florida facility

    Medical Dialogues Bureau21 Jan 2020 11:28 AM IST
    The Florida facility is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations...
    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Medical Dialogues Bureau21 Jan 2020 10:00 AM IST
    "We are looking at a revenue of over Rs 1,000 crore for the fiscal year 2022. It will be achieved through organic and inorganic growth," Trivitron...
    Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

    Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

    Medical Dialogues Bureau20 Jan 2020 12:00 PM IST
    Kiran Mazumdar Shaw, Biocon founder and an Australian Global Alumni Ambassador, is also recognised for her sustained and significant contribution to...
    Lupin gets 5 USFDA observations for Vizag facility

    Lupin gets 5 USFDA observations for Vizag facility

    Medical Dialogues Bureau20 Jan 2020 11:24 AM IST
    The inspection for the API facility at Vizag closed with five 483 observations, Lupin said. New Delhi: Drug firm Lupin on Saturday said it has...
    NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

    NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

    Medical Dialogues Bureau20 Jan 2020 11:02 AM IST
    New Delhi: The Narcotics Control Bureau(NCB) has unearthed an inter-state racket of psychotropic medicine traffickers with the seizure of over 7 lakh...
    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Medical Dialogues Bureau20 Jan 2020 10:00 AM IST
    Beijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
    ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

    ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

    Medical Dialogues Bureau20 Jan 2020 9:45 AM IST
    New Delhi: ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava's novel...
    Drugs and Magic Remedies act to cover online, electronic media; have higher penalties

    Drugs and Magic Remedies act to cover online, electronic media; have higher penalties

    Farhat Nasim19 Jan 2020 11:15 AM IST
    New Delhi: In a stringent view to regulate the menace of misleading advertisements opted tactfully by many companies to enhance the sale of their...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok